Literature DB >> 16865299

Reperfusion strategy for acute myocardial infarction in elderly patients aged 75 to 80 years.

Ikuyoshi Watanabe1, Ken Nagao, Shigemasa Tani, Naoki Masuda, Takaharu Yahata, Sumito Ohguchi, Katsuo Kanmatsuse, Toshio Kushiro.   

Abstract

The increasing elderly population will influence the treatment policies adopted in cases of acute myocardial infarction. Considering reperfusion therapy in elderly patients with acute myocardial infarction, we compared three strategies, as follows: primary percutaneous coronary intervention (primary PCI: n = 26), facilitated PCI with half the standard dose of mutant tissue-type plasminogen activator (t-PA) (half + PCI: n = 24), and facilitated PCI with a standard dose of mutant t-PA (standard + PCI: n = 15) between patients 75 and 80 years of age. The rate of acquisition of thrombolysis in myocardial infarction (TIMI-3) flow on initial coronary arteriography was significantly lower in the primary PCI group than in the other two groups (7.7% in the primary PCI group vs 60% in the half + PCI and 66.7% in the standard + PCI group). The incidence of hemorrhagic complications including blood transfusion was not significantly different between primary PCI and facilitated PCI. Considering reperfusion therapy in elderly patients with acute myocardial infarction, we concluded that facilitated PCI may be effective in elderly patients aged 75-80 years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865299     DOI: 10.1007/s00380-005-0897-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   1.814


  19 in total

1.  1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; S C Smith
Journal:  Circulation       Date:  1999-08-31       Impact factor: 29.690

2.  Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).

Authors:  A J Tiefenbrunn; N C Chandra; W J French; J M Gore; W J Rogers
Journal:  J Am Coll Cardiol       Date:  1998-05       Impact factor: 24.094

3.  Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.

Authors:  H D White; G I Barbash; R M Califf; R J Simes; C B Granger; W D Weaver; N S Kleiman; P E Aylward; J M Gore; A Vahanian; K L Lee; A M Ross; E J Topol
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

4.  A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.

Authors:  A M Ross; K S Coyne; J S Reiner; S W Greenhouse; C Fink; A Frey; E Moreyra; M Traboulsi; N Racine; A L Riba; M A Thompson; S Rohrbeck; C F Lundergan
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

5.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; J L Anderson; E M Antman; B A Braniff; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B J Riegel; R O Russell; E E Smith; W D Weaver
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

6.  Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials.

Authors:  G W Stone; D Cox; E Garcia; B R Brodie; M C Morice; J Griffin; L Mattos; A J Lansky; W W O'Neill; C L Grines
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

7.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

8.  Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial.

Authors:  David A Morrow; Elliott M Antman; Assaad Sayah; Kristin C Schuhwerk; Robert P Giugliano; James A deLemos; Michael Waller; Sidney A Cohen; Donald G Rosenberg; Sally S Cutler; Carolyn H McCabe; Ron M Walls; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

9.  An early and complete reperfusion strategy for acute myocardial infarction using fibrinolysis and subsequent transluminal therapy--The FAST trial.

Authors:  Ken Nagao; Nariyuki Hayashi; Katsuo Kanmatsuse; Satoru Kikuchi; Tomiya Ohuba; Hiroshi Takahashi
Journal:  Circ J       Date:  2002-06       Impact factor: 2.993

10.  Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.

Authors:  G W Stone; C L Grines; K F Browne; J Marco; D Rothbaum; J O'Keefe; G O Hartzler; P Overlie; B Donohue; N Chelliah
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

View more
  3 in total

1.  Influence of diabetes on >10-year outcomes after percutaneous coronary intervention.

Authors:  Takatoshi Kasai; Katsumi Miyauchi; Kan Kajimoto; Naozumi Kubota; Takeshi Kurata; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

2.  Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction.

Authors:  Katsunori Shimada; Hiroshi Kasanuki; Nobuhisa Hagiwara; Hiroshi Ogawa; Naohito Yamaguchi
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

3.  Impact of anemia on nonfatal coronary events after percutaneous coronary interventions.

Authors:  Alp Burak Catakoglu; Saide Aytekin; Murat Sener; Hilal Kurtoglu; Huseyin Celebi; I C Cemsid Demiroglu; Vedat Aytekin
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.